Rosenberger Brian 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Feb 3, 2020
Insider Transaction Report
Form 4
Rosenberger Brian
VP, Commercial
Transactions
- Award
Stock Option (right to buy)
2020-01-30+48,000→ 48,000 totalExercise: $5.05Exp: 2030-01-30→ Common Stock (48,000 underlying) - Award
Stock Option (right to buy)
2020-01-30+10,000→ 10,000 totalExercise: $5.05Exp: 2030-01-30→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.
- [F2]The stock option vests 100% on the fourth anniversary of the date of the grant, subject to continued employment with the Company.